Boston Children's Hospital Post Anesthesia Care Unit Outcomes Study

计划入组 643 人 · 首次发布于 2014 年 7 月 14 日

Blood Transfusion by Boston MedFlight Registry

计划入组 500 人 · 首次发布于 2020 年 11 月 2 日

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

计划入组 200 人 · 首次发布于 2025 年 7 月 31 日

Ezh2 inhibitors (Dana-Farber Cancer Institute/Boston Children's Hospital)

X-SCID gene therapy, Children's Hospital Boston/Dana-Farber Cancer Institute

dBET57(Dana-Farber Cancer Institute)

Dana-Farber/Harvard Cancer Center

United States

DANA FARBER CANCER INSTITUTE

United States

DANA-FARBER CANCER INSTITUTE

United States

Agios' Mitapivat Achieves Primary Endpoint in Phase 3 Trial for Children with PK Deficiency

Dana-Farber, Boston Children's Hospital, and Broad Clinical Labs Launch BrightSeq Initiative for Pediatric Cancer Genomics

Dana-Farber Presents Breakthrough Findings in Blood Cancer Treatment at ASH 2025